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Abstract: In various tissues, glucocorticoids (GCs) are known to downregulate glucose transport systems;
however, their effects on glucose transporters (GLUTs) in the placenta of a diabetic rat are unknown. Gluco-
corticoid hormone action within the cell is regulated by the glucocorticoid receptor (GR). Thus, this study was
designed to investigate the relationship between GR and glucose transporter expression in the placenta of the
diabetic rat. Our immunohistochemical results indicated that GR and glucose transporter protein 1 (GLUT 1)
are expressed ubiquitously in the trophoblast and endothelial cells of the labyrinthine zone, where maternal
fetal transport takes place in the rat placenta. Expression of GR in the junctional zone of the rat placenta was
detected in giant cells, and in some spongiotrophoblast cells, but not in the glycogen cells. GLUT 1 was present,
especially in glycogen cells during early pregnancy, and in the spongiotrophoblast cells of the junctional zone
during late pregnancy. Amounts of GR and GLUT 1 protein were increased towards the end of gestation both
in the control and the diabetic placenta. However, at days 17 and 19 of gestation, only the placental GR
protein was significantly increased in the streptozotocin-induced diabetic rats compared to control rats. Dia-
betes led to a significant decrease in placental weight at gestation day 15.  In contrast, at gestational days 17
and 21, the weights of the diabetic placenta were significantly increased as compared with the controls. More-
over, diabetes induced fetus intrauterine growth retardation at gestational days 13, 17 and 21. In conclusion,
the localization pattern of GR and GLUT 1 proteins in the same cell types led us to believe that there might be
a relationship between GR and GLUT 1 expressions at the cellular level. GLUT 1 does not play a pivotal role
in diabetic pregnancies. However, placental growth abnormalities during diabetic pregnancy may be related to
the amount of GR. (Folia Histochemica et Cytobiologica 2011; Vol. 49, No. 2, pp. 325–334)
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 Introduction
The placenta, a complex organ of limited life-span
whose metabolic and endocrine activities are not yet
fully understood, is the organ responsible for the
transfer of nutrients and waste products between the
fetal and maternal circulations. The placenta must
integrate signals from the fetus and the mother in an
attempt to match fetal demand with maternal sub-
strate supply [1]. Therefore, it plays a pivotal role in
fetal growth. The failure of placental growth and de-
velopment during early and middle stages of preg-
nancy is directly associated with decreased fetal
growth in late pregnancy [2].
Rat placenta is composed of two main regions,
the junctional zone (JZ) and the labyrinthine zone
(LZ). The LZ is located at the fetal interface and
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comprises stem cells capable either of differentiating
into trophoblast giant cells, or of fusing to form syn-
cytial trophoblast cells. Labyrinthine trophoblast gi-
ant cells possess a restricted capacity for hormone
production [3], whereas syncytial trophoblast cells
mediate the transfer of nutrients and wastes between
maternal and fetal compartments [4]. The JZ repre-
sents the interface between the maternal and fetal
tissues, and is the site of trophoblast proliferation.
The LZ of the trophoblast consists of three morpho-
logically distinct cell types: trophoblast giant cells,
spongiotrophoblast cells, and glycogen cells [5].
Trophoblast giant cells arise by endoreduplica-
tion, are situated at the maternal/placental inter-
face, and are one of the major endocrine cells of
the placenta [3]. They synthesize and secrete ste-
roid and peptide hormones. Spongiotrophoblast
cells are located immediately beneath the tropho-
blast giant cell layer, and synthesize and secrete
peptide hormones. Glycogen cells are a transient
cell type embedded among the spongiotrophoblast
cells. Beyond their accumulation of glycogen, their
biology is not well understood [3].
Glucose, a primary energy substrate for fetal and
placental development, is the principal carbohydrate
to be transported by the placenta. It is transferred
across the placenta by sodium-independent facili-
tated diffusion along a concentration gradient
[6, 7]. In general, a family of transporter proteins
mediates this process. These glucose transporters
(GLUTs) are characterized by the presence of 12
membrane-spanning helices and several conserved
sequence motifs. Twelve different facilitative glucose
or fructose transporter isoforms, GLUT 1-GLUT 12,
have been cloned [8]. GLUT proteins show a tissue-
specific distribution. The predominant form ex-
pressed in the placenta during early pregnancy is
GLUT 1, the tissue-barrier isoform seen in tropho-
blastic cell plasma membranes [9, 10].
On the other hand, the placenta is a glucocorti-
coid target organ per se, with placental growth
[11, 12] and endocrine function known to be affected
by GCs [13]. Glucocorticoid hormone action within
the cell is regulated by expression of the GR and iso-
forms of 11b-hydroxysteroid dehydrogenase1 and 2
(11b HSD1 and 11b HSD2) [14–16]. Therefore, many
classical effects of GCs are mediated by GR [14]. Fetal
GCs are derived from the mother and are present in
low concentrations until the end of gestation. The
transplacental GCs concentration gradient is main-
tained by placental 11b HSD2, which converts the
active GCs, cortisol and corticosterone, to their inac-
tive metabolites [17]. Consequently, precise control
of the transplacental transfer of maternal glucocorti-
coids to the fetus is critical for placental and fetal
development. GCs could potentially affect a wide
range of cellular functions within the embryo and
placenta, from trophoblast differentiation soon after
implantation, to hormone synthesis in the fully dif-
ferentiated placenta [18].
Additionally, GCs specifically inhibit glucose
transport in a variety of peripheral tissues, such as
skeletal muscle, adipocytes, and endothelial cells
[19–21]. Furthermore, placental glucose transport-
ers expressions are regulated by GCs [22].
Maternal diabetes is one of the commonest com-
plications during pregnancy. The altered metabolic
environment in maternal diabetes during pregnancy
interferes with normal placental and fetal develop-
ment. In humans, as well as in rodents, there is an
increased incidence of congenital malformations and
fetal growth retardation. The exposure of the placenta
to a diabetic environment may lead to functional and
structural derangements, including villous immatu-
rity, enlargement of the surface area of exchange and
thickening of the basement membrane [1].
In short, inadequate transfer of compounds be-
tween mother and fetus can cause abnormalities in
the developing fetus. This means that studies during
placentation in diabetic rats are of great importance.
It is hypothesized that GCs regulate placental glu-
cose transport in many cell types and tissues. There-
fore, the aim of this study was to investigate the rela-
tionship between glucose transport and the glucocor-
ticoid metabolism in rat placental development of
normal and diabetic pregnancy, focusing on the GR
and GLUT 1 protein.
Material and methods
Animals. Female albino rats (Rattus norvegicus) (250–270 g)
were kept at a temperature of 22 ± 2°C and maintained
on a cycle of 12 hours light/12 hours darkness, with free
access to food and water. The rats had been kept in cages,
as with two female per one male rat. The onset of pregnan-
cy was determined by vaginal smear inspection to see sper-
matozoa after overnight mating. The day when a positive
smear was found was designated day 0 of pregnancy. Dia-
betes mellitus was experimentally induced by a single intra-
peritoneal (i.p.) injection of 60 mg/kg body weight strepto-
zotocin (STZ, Sigma Chemical Co. S 0130) 50 mM sodium
citrate buffer, pH 4.5 on day six of gestation. Control rats
received an equal volume of citrate buffer. After two days
of STZ injection, diabetes was confirmed when blood glu-
cose concentration was measured to be greater than 250
mg/dl. On days 13, 15, 17, 19 and 21 of pregnancy, rats were
anesthetized with ether. The experimental design and num-
ber of animals, placentas and embryos is shown in Table 1.
The anterior abdominal wall was opened and placentas and
fetuses were collected and rapidly weighed. Some of the
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placentas were excised and frozen in liquid nitrogen, and
kept at –80°C until required for Western blots. The remain-
ing placentas were fixed for four hours in Holland’s fixative
for immunohistochemistry.
Immunohistochemistry. Immunohistochemistry was per-
formed on paraffin-embedded tissue sections of the devel-
oping diabetic and control rat placentas between gestation-
al days (GD) 13 and 21.
The paraffin-embedded serial sections (6 mm) were
collected on SuperFrost Plus slides (Novoglas, Berne,
Switzerland). After re-hydration, samples were trans-
ferred to 0.01 M citrate buffer (pH = 6) and subsequent-
ly heated in a microwave oven for 2 × 5 minutes at 750 W
for antigen-retrieving. After cooling for 20 minutes at
room temperature, the sections were washed with PBS.
To remove endogenous peroxidase activity, sections were
kept in 3% H2O2 for 20 minutes, and afterwards washed
with PBS. Sections were incubated for 60 minutes at room
temperature in a moist chamber with two rabbit antisera
one against to C-terminal sequences of GLUT 1 (AB 1340
from Chemicon, Temecula, CA, USA) and the other two
N-terminal sequences of GR (Sc-1004 from Santa Cruz
Biotechnology, Santa Cruz, CA, USA). Antisera were
diluted 1:1,000 (GR), and 1:2,000 (GLUT 1) with Anti-
body Diluent (Dako, Carpinteria, CA, USA). Labeling
was visualized using the Universal LSAB 2 Kits (Dako,
K 0609) according to the instructions of the manufacturer.
The sections were counterstained with Mayers’s hemalum
(Merck, Darmstadt, Germany) and mounted with Kai-
ser’s glycerol gelatin (Merck). For controls, sections were
incubated with rabbit serum (Dako X 0902). Photographs
were taken with an Axiophot microscope (Zeiss,
Oberkochen, Germany).
Investigations were conducted in accordance with the
Guide for the Care and Use of Laboratory Animals (Insti-
tute for Laboratory Animal Research of the National Acad-
emy of Science, Bethesda, MD, USA, 1996).
SDS-polyacrylamide gel electrophoresis and Western
blotting. Cellular proteins from diabetic and control rat
placenta were solubilized in Laemmli sample buffer (Sig-
ma) supplemented with CompleteR protease inhibitor
cocktail (Boehringer, Mannheim, Germany). Insoluble
material was removed by centrifugation at 100,000 × g
for 1 hour at 4°C. Samples were stored at –70°C. Prior to
electrophoresis, samples were boiled for three minutes
at 100°C.
Table 1. Experimental design and number of animals, placentas and embryos
Group 1: Normal experimental group
Group 2: Diabetic experimental group
Group 1: Normal experimental group
Animals number n = 4 n = 4 n = 4 n = 4 n = 4
Placenta and embryos number n = 43 n = 38 n = 35 n = 35 n = 37
Group 2: Diabetic experimental group
Animals number n = 4 n = 4 n = 4 n = 4 n = 4
Placenta and embryos number n = 34 n = 26 n = 29 n = 27 n = 31
MoBG — measurement of blood glucose; IoP — interruption of pregnancy; DoP — days of pregnancy
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Amounts of protein were determined according to
Lowry et al. [23] and 50 μg protein was applied to each
lane. Samples were subjected to SDS-polyacrylamide gel
electrophoresis on 8–18% gradient gels (ExcelGel; Phar-
macia, Uppsala, Sweden) using SDS buffer strips
(ExcelGel, Pharmacia). Samples were run for 150 minutes
at a constant 600 V/50 mA/30 W. Proteins were trans-
ferred onto nitrocellulose membranes (Pharmacia) by
semi-dry electroblotting in a buffer containing 0.2 mol/l
glycine, 25 mM Tris and 20% methanol for 45 minutes at
30 V/100 mA/6 W. Successful transfer was confirmed by
Ponceau S (Sigma) staining of the blots. The membranes
were blocked for 1 hour with 5% non-fat dry milk (Bio-
-Rad, Hercules, CA, USA) and 0.1% Tween-20 (Sigma)
in 0.14 mol/l Tris-buffered saline (TBS) pH 7.2–7.4 at 4°C.
The same solution was used for subsequent washing steps
and as a diluent for the antibodies. The blotting mem-
branes were incubated overnight at 4°C with rabbit anti-
sera against GLUT 1 (1:3,000) and GR (1:200). After
washing, the membranes were further incubated with goat
anti-rabbit IgG horseradish peroxidase conjugate (Bio-
-Rad) diluted 1:2,000 for 1 hour at room temperature.
After three washing steps in TBS, pH 7.2–7.4, immuno-
labeling was visualized using the chemiluminescence-
based SuperSignal CL-HRP Substrate System (Pierce,
Rockford, IL, USA) according to the manufacturer’s in-
structions. Membranes were exposed to Hyperfilm (Am-
ersham), which was subsequently scanned using an Al-
pha Digi DocTM densitometer and quantified with Al-
phaEaseFC software (Alpha Digi Doc 1000). Control
blots were incubated with antibody diluent alone.
Statistical analysis. Results are presented as mean ± stan-
dard error of mean (SEM). Comparisons between the con-
trols and the diabetic groups were performed by Mann–
–Whitney U tests for individual comparisons or Students
t-test as appropriate. Statistical calculations were performed
using Sigmastat Program for Windows, version 2.0 (Jandel
Scientific Corporation, San Rafael, CA, USA).
Results
Measurement of maternal glucose
Blood glucose level was routinely determined us-
ing a glucometer according to the user’s guide, with
certain modifications. Blood samples were collect-
ed from rat tail veins and a drop of blood was ap-
plied to the pad of the glucose strips. After 20 sec-
onds, the pad surface was carefully blotted dry and
inserted into the test slot of the glucometer. We
measured the maternal glucose concentration dur-
ing gestational days 13, 15, 17, 19, 21. The data is
shown in Figure 1A.
Hyperglycemia effects on placenta
and body weights of fetus
The fetuses and the placentas were weighed from
GD13 to GD21. The fetuses of the diabetic rat mod-
el showed intrauterine growth retardation compared
to the fetuses of the control group. Significant dif-
ferences were observed in fetal weight between the
control and diabetic groups on GD13, GD17 and
GD21 (p < 0.001 by Mann–Whitney U test) (Fig-
ure 1B). Placental weights of diabetic mothers were
A
B
C
Figure 1. A. Measurements of maternal glucose concen-
tration in STZ-induced diabetic group; B. Fetal body;
C. Placental weights of control and STZ-diabetic group
from days 13 to 21 of pregnancy. Results are presented
as means ± SEM. Both were tested by the Mann–
–Whitney U test. Statistically-significant effects of GR
expression in the diabetic rat placenta are indicated by:
**p< 0.005; *p < 0.001
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significantly lower on GD15 (p < 0.05 by Mann–
–Whitney U test) and higher on GD17 and GD21
(p < 0.001 by Mann–Whitney U test) than the pla-
cental weights from control rats (Figure 1C).
Localization of GR and GLUT 1 proteins
by immunohistochemistry
During the development of the normal and diabetic
rat placenta, we determined the immunocytochemi-
cal localization of GR and GLUT 1 proteins. The data
from the immunohistochemistry is summarized in Ta-
ble 2. The two observers were always concordant, ex-
cept for the assessments of weak to moderate staining.
Chorioallantoic placenta
The chorioallantoic placenta consists of two distinct
zones: the LZ, the major site of maternal fetal ex-
change, and the JZ, the primary site of placental ste-
roid and peptide hormone synthesis.
Localization of GR
On the 13th day of pregnancy of the normal and dia-
betic rat placenta, there was GR expression mainly
in the LZ, but also in the JZ at particularly high lev-
els in the trophoblast cells and endothelial cells sur-
rounding the maternal blood vessels (Figure 2A).
From the 15th to the 21st day of pregnancy, GR was
detected in decidual cells, giant cells, and some spon-
giotrophoblast cells of the JZ. Endothelial cells, lab-
yrinth trophoblast cells and labyrinthic giant cells were
immunopositive for GR. However, glycogen cells did
not react with GR (Figures 2C, E). The expression level
of GR was increased, especially in endothelial cells of
the LZ and spongiotrophoblast cells of JZ in the dia-
betic rat placenta (Figures 3C, D) compared to nor-
mal placenta (Figures 3A, B) on GD17 and GD19.
Localization of GLUT 1
GLUT 1 expression was restricted to the LZ, espe-
cially in the endothelial cells of fetal vessels on the
13th day of pregnancy (Figure 2B). From the 15th to
the 21st day of pregnancy, GLUT 1 was present espe-
cially in glycogen cells and some spongiotrophoblast
cells from the JZ. Endothelial cells and some tropho-
blast cells of the LZ were immunopositive for GLUT 1
(Figures 2D, F). The reaction pattern of GLUT 1 re-
mained constant from GD15 to GD 21, with only
slight changes in intensity (Table 2).
Expression levels of GLUT 1 were increased to-
wards the end of gestation, especially spongiotropho-
blast cells of JZ and endothelial cells of the LZ in the
diabetic rat placenta (Figures 3E, F). One of the char-
acteristic properties of diabetic placenta is numerous
cysts and glycogen cells which are immunopositive for
GLUT 1 (Figure 3H) but not GR (Figure 3G).
Yolk sac placenta
The yolk sac placenta is composed of parietal yolk
sac and visceral yolk sac, the second site for mater-
nal-fetal exchange. GR (Figure 2G) but not GLUT 1
(Figure 2H) were detected in the fetal mesenchymal
cells. Yolk sac epithelium was immunopositive for
GLUT 1 (Figure 2H) but not GR (Figure 2G). GLUT 1
was not found in the parietal and visceral endoder-
mal cells, but visceral endodermal cells were immu-
nopositive for GR (data not shown).
Expression of GLUT 1 and GR
in the placenta on immunoblots
GR and GLUT 1 protein expressions as quantified
by Western blotting in normal and diabetic rat pla-
centas from GD13 to GD21 are shown in Figures 4A, B.
GR and GLUT 1 proteins were detected by Western
blot analysis as single bands at the expected sizes of
95 and 54 kDa, respectively. Amounts of the control
and diabetic placental GR and GLUT 1 proteins in-
creased towards gestational days (Figures 4A, B).
However, only the placental GR protein at GD17 and
GD19 day was significantly increased in the STZ-di-
abetic rats compared to the control rats (p < 0.001,
Figure 4A).
Discussion
Our study demonstrates, for the first time, the spa-
tial and temporal localization patterns of GR and
GLUT 1 proteins in diabetic rat placenta.
Glucocorticoid dynamics during diabetic pregnan-
cy is a controversial issue. Plasma corticosterone lev-
els at term are dependent on the severity of maternal
diabetes [24]. Maternal and fetal plasma corticoster-
one levels of diabetic rats were significantly lower than
the corresponding control values between GD19 and
GD22 [25]. We detected GR expression to be signif-
icantly increased between the 17th and 19th days of
pregnancy in diabetic rats. Van Beek et al. [26] estab-
lished that GCs increase 11b-HSD2 activity and
mRNA expression, but conversely decrease GR
mRNA expression in cultured human trophoblast
cells. Additionally, treatment of trophoblasts with the
GR antagonist RU-486 blocked the glucocorticoid-
-induced increase of 11b-HSD2 activity, indicating
that the effect of GCs on 11b-HSD2 is probably me-
diated by GR [26].
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In this study, we failed to detect 11b-HSD2 in rat
placenta during pregnancy, but a previous study
showed 11b-HSD2 gene expression to be decreased
in placentas of STZ-induced diabetic pregnant rats
[27]. Our data demonstrating the increased levels of
GR protein in the placentas of STZ-induced diabet-
ic rats in late pregnancy may indicate that 11b-HSD2
is mediated by GR, similar to the results obtained by
Van Beek et al. [26]. Our data suggests that diabetic
rat placentas show increased expression towards the
GR and sustain the catabolism of corticosterone.
We found that GR protein expression in endothe-
lial cells of the LZ was associated with the maternal
blood vessels; thus GR is ideally located for its pro-
posed role in regulating the transplacental passage of
maternal glucocorticoid to the fetus by the mechanism
to protect the fetal compartment from high levels of
maternal glucocorticoids. Expression of GR protein
was detected in both labyrinthic and junctional layers
of rat placenta, indicating these two important sites
are glucocorticoid target sites. Therefore, the co-ex-
pression of GLUT 1 with GR protein in trophoblast
cells of the LZ and in the spongiotrophoblast cells of
the JZ may suggest that GR activity might participate
in regulating local glucocorticoid-mediated cellular
differentiation, placental growth and function, such as
expressions of glucose transporters proteins.
GR was abundantly expressed in the spongiotro-
phoblast and giant cells of the JZ. Therefore, GCs
may regulate placental synthesis of both steroid and
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Table 2. Distribution of GR and GLUT 1 immunoreactivity in the normal and diabetic rat placenta and uterus at
GD13, GD15, GD17, GD19 and GD21a
13 1 1 2 0 1 – 2 – – Diabetic
1 1 2 0 1 – 2 – – Control
15 1 2 2 0 1 3 2 0 2 Diabetic
1 2 2 0 1 2 2 0 2 Control
17 1 3 3 0 1 3 3 0 3 Diabetic
1 2 2 0 1 2 2 0 2 Control
19 1 3 3 0 1 3 3 0 3 Diabetic
1 2 2 0 1 2 2 0 2 Control
21 1 3 3 0 1 2 3 0 2 Diabetic
1 2 2 0 1 2 2 0 2 Control
13 1 0 0 0 1 – 2 – – Diabetic
1 0 0 0 1 – 2 – – Control
15 1 1 2 0 1 0 2 1 0 Diabetic
1 1 2 0 1 0 2 1 0 Control
17 1 1 2 0 2 0 3 1 0 Diabetic
1 1 2 0 2 0 3 1 0 Control
19 1 3 2 0 2 0 3 1 0 Diabetic
1 2 1 0 2 0 3 1 0 Control
21 1 3 2 0 2 0 3 1 0 Diabetic
1 2 1 0 2 0 3 1 0 Control
aThis table was designed according to the percentage of positively stained cell count; 3, 2, 1, and 0 indicate the differences in signal intensities
observed by optical microscopy and reflect levels of GR and GLUT 1 proteins: 0 = absent; 1 = weak expression (10–30%); 2 = moderate
expression (40–60%); and 3 = high expression (70–100%). Empty cells in the table indicate the concerned tissue is either not yet differentiated or
has not been investigated at the respective gestational days
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peptide hormones. During diabetes, several metabolic
adjustments take place to tailor high circulating blood
glucose levels. Glucocorticoid and GR might play
a critical role in such metabolic conditions.
In various tissues, GCs down-regulate glucose
transport systems; however, their action on glucose
transport systems in placenta is unknown, especially
in the diabetic placenta. Previous studies found that,
in rats treated with GCs from day 15 to day 21 of
pregnancy, placental GLUT 1 and GLUT 3 protein
expressions increased dose-dependently. Increased
Figure 2. Transverse sections of the developing rat placenta
from GD13 (A, B), GD15 (C, D), GD17 (E, F), and GD19
(G, H). A. GR. Arrowheads point to labyrinthine tropho-
blast, arrows point to fetal endothelial cells in the LZ.
B. GLUT 1. Arrows point to fetal endothelial cells. Arrowhe-
ads indicate an immunonegative labyrinthine trophoblast
and yellow arrowheads indicate immunonegative spongio-
trophoblast cells. Inset shows the negative control staining
for GLUT 1. C. GR. Arrowheads point to labyrinthine
trophoblast, arrows point to fetal endothelial cells, yellow
arrowheads indicate spongiotrophoblast cells and red
arrowheads indicate an immunonegative glycogen cell.
D. GLUT 1. Red arrowheads point to glycogen cells, arrows
point to fetal endothelial cells, yellow arrowheads indicate
spongiotrophoblast cells and arrowheads indicate labyrinthi-
ne trophoblast. E. GR. Arrowheads point to labyrinthine
trophoblast, blue arrowheads point to giant cells, arrows
point to fetal endothelial cells, and red arrowheads indicate
immunonegative glycogen cells. F. GLUT 1. Red arrowhe-
ads point to glycogen cells, arrows point to fetal endothelial
cells, arrowheads indicate labyrinthine trophoblast cells,
yellow arrowheads indicate spongiotrophoblast cells and
blue arrowheads indicate immunonegative giant cells.
G. GR. arrowheads point to fetal mesenchymal cells, arrows
point to endothelial cells of the umbilical vessels, blue arrows
point to immunonegative yolk sac epithelial cells, and yellow
arrows indicate immunonegative parietal cells on the
reichert membrane. H. GLUT 1. Arrowheads point to
immunonegative fetal mesenchymal cells, blue arrows point
to yolk sac epithelial cells, arrows point to immunonegative
endothelial cells of the umbilical vessels, and yellow arrows
indicate immunonegative parietal cells on the reichert
membrane
GD — gestational day; JZ — junctional zone; LZ — labyrinth zone.
Magnification × 300 for B, C, D, G, H; × 600 for A, E, F
Figure 3. Transverse sections of the control (A, B) and
diabetic rat placenta from GD19 (C, D) and GD21 (E, F).
A. GR. Yellow arrowheads indicate spongiotrophoblast
cells. B. GR. Arrowheads point to labyrinth trophoblast,
blue arrowheads point to labyrinth giant cells and arrows
point to fetal endothelial cells. C. GR. Yellow arrowheads
indicate spongiotrophoblast cells. D. GR. Arrowheads
point to labyrinthine trophoblast, blue arrowheads point to
labyrinthine giant cells and arrows point to fetal endothelial
cells. E. GLUT 1. Yellow arrowheads indicate spongiotro-
phoblast cells. F. GLUT 1. Arrowheads point to basement
membrane of labyrinthine trophoblast cells; arrows indicate
basement membrane of fetal endothelial cells. G. GR.
Yellow arrowheads indicate spongiotrophoblast cells. Inset
shows the negative control staining for GR. H. GLUT 1.
Yellow arrowheads indicate spongiotrophoblast cells and
red arrowheads point to glycogen cells
GD — gestational day; JZ — junctional zone; LZ —labyrinth zone;
Gly C — glycogen cell. Magnification × 300 for G, H; × 600 for A–F
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A
B
Figure 4. A. Western blot analysis of GR from control
and diabetic placenta. Values are expressed as mean ±
± SEM of ratio of control GD13 GR levels. Statistically
significant effects of GR expression in the diabetic rat
placenta are indicated by: *p< 0.001. B. Western blot
analysis of GLUT 1 from control and diabetic placenta.
Values are expressed as mean ± SEM of ratio of control
GD13 GLUT 1 levels. Statistically significant effects of
GLUT 1 expression in the diabetic rat placenta are not
indicated
placental GLUT 1 and GLUT 3 protein expressions
may reflect an attempt to increase placental or fetal
glucose supply to attenuate the effect of excessive
exposure to GCs in diminishing fetal growth [28]. In
contrast, both GLUT 1 and GLUT 3 transcripts and
proteins were significantly downregulated in isolat-
ed human trophoblast cells and in rat placentas by
exposure to GCs [22]. The results of previous studies
show that expressions of GLUT 1 and GLUT 3 pro-
teins in the rat placenta are differentially affected by
GC treatment. Our result regarding the protein lev-
els of GR and GLUT 1 showed that the glucose trans-
port system was working independently from GR pro-
tein expression in normal and diabetic placenta. How-
ever, both GR and GLUT 1 proteins were expressed
in spongiotrophoblast cells, endothelial cells and tro-
phoblast cells at the same time. So, there may also be
an autocrine regulation between GR and GLUT 1.
Ogura et al. [29] demonstrated that GLUT 1 pro-
tein in placentas from diabetic mice was significantly
decreased compared to controls. In spite of this, we
determined that the expression level of GLUT 1 pro-
tein was not different in the developing normal rat
placenta compared to diabetic placenta. Other reports
have found no significant change in rat placental
GLUT 1 protein levels after STZ [30, 31] and glu-
cose [32] treatment, mirroring our data. Conversely,
GLUT 3 mRNA and protein expressions in diabetic
rat placentas increased compared to controls [30, 31].
Our immunohistochemical results showed that GLUT 1
protein was localized mainly in the membranes on
both sides of the trophoblast cells that predominant-
ly line the labyrinthine maternal vascular spaces, and
abundantly in the fetal endothelial cells. These find-
ings suggest that GLUT 1 expression in the rat pla-
centa is specifically localized in cells responsible for
transplacental glucose transport. On the other hand,
we showed for the first time that there is a higher
expression of GLUT 1 in the glycogen cells in early
pregnancy compared to late pregnancy. This phenom-
enon may protect fetuses from glucose toxicity and
deposit glucose as glycogen, an energy resource for
placental development.
The placental weights of STZ induced diabetic
rats at term are higher than those of control ani-
mals [33]. By contrast, the weight and nucleic acid
content of diabetic rat placenta on days 14 and 16
of gestation are significantly lower [34]. We found
placental weights of diabetic mothers were signifi-
cantly lower on GD15 and higher on GD17 and
GD21 (p < 0.001 by Mann–Whitney U test) than
placental weights from control rats (Figure 1C). Our
data supported the previous studies and suggests that
perhaps glucose inhibits proliferation in the diabet-
ic placental cells in the early gestational stage, and
as a result placental growth diminished. The prolif-
erative activity of diabetic placental cells was found
to be high on GD17 and GD21.
The fetuses of our diabetic model showed intrau-
terine growth retardation compared to fetuses of the
control group. These observations showed that pla-
cental GLUT 1 protein expression could not be stim-
ulated under hyperglycemic conditions. Thus, perhaps
another glucose transporter isoform, such as GLUT 3,
may play a pivotal role in the severe alterations of
placental function observed in diabetic pregnancies.
Our findings indicated that STZ-induced diabe-
tes increased the activation of placental GR in late
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pregnancy that might influence the differentiation
process via GCs in placenta. The precise mechanisms
of GR regulation in STZ-induced diabetes are, how-
ever, unclear. Moreover, it will be of much clinical
significance, in future, to unravel the correlation be-
tween STZ-induced diabetes and the regulation of
GR function. Further investigation is necessary to
clarify the role of GR in the diabetic rat placental
glucose transport mechanism.
In conclusion, the localization pattern of GR
and GLUT 1 proteins in the same cell types led us
to believe that there might be a relationship be-
tween GR and GLUT 1 expressions at the cellular
level. GLUT 1 does not play a pivotal role in dia-
betic pregnancies. However, placental growth ab-
normalities during diabetic pregnancy may be re-
lated to the amount of GR.
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